Year-End Amendment — INFECTIOUS DISEASES SOCIETY OF AMERICA for INFECTIOUS DISEASES SOCIETY OF AMERICA (2007)

Firm

INFECTIOUS DISEASES SOCIETY OF AMERICA

Client

INFECTIOUS DISEASES SOCIETY OF AMERICA

Income

—

Expenses

$219,566

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Medical liability; Antimicrobial resistance research; infectious diseases product research and development.

Lobbyist	Covered position, as disclosed
ROBERT J GUIDOS	DIRECTOR, PUBLIC POLICY & GOV'T RELATIONS
JULIE HANTMAN	SENIOR PROGRAM OFFICER FOR PUBLIC HEALTH
CHRISTINE LUBINSKI	—
R MICHAEL OCHS	GOVERNMENT RELATIONS ASSOCIATE
BETH RADA	PROGRAM OFFICER FOR SCIENCE & RESEARCH
JASON SCULL	PROGRAM OFFICER FOR CLINICAL AFFAIRS
ANDREA WEDDLE	ASSOCIATE DIRECTOR, HIV MEDICINE ASSOICIATION

Contacted: Food & Drug Administration (FDA); SENATE; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Reimbursement for outpatient infusion therapy; Physician payment cuts; Medicaid and Medicare Reform, including Medicare Prescription Drug Coverage; Average Sales Price; and Competitive Acquisition Program

Lobbyist	Covered position, as disclosed
ROBERT J GUIDOS	DIRECTOR, PUBLIC POLICY & GOV'T RELATIONS
JULIE HANTMAN	SENIOR PROGRAM OFFICER FOR PUBLIC HEALTH
CHRISTINE LUBINSKI	—
R MICHAEL OCHS	GOVERNMENT RELATIONS ASSOCIATE
BETH RADA	PROGRAM OFFICER FOR SCIENCE & RESEARCH
JASON SCULL	PROGRAM OFFICER FOR CLINICAL AFFAIRS
ANDREA WEDDLE	ASSOCIATE DIRECTOR, HIV MEDICINE ASSOICIATION

Contacted: Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA)

Health Issues HCR

Infectious Diseases; drug and vaccine research and development; antimicrobial resistance; immunizations; pandemic influenza, public health security and bioterrorism; global infectious diseases; biomedical research, Ryan White Reauthorization; Lyme disease and other infectious diseases issues.

Lobbyist	Covered position, as disclosed
ROBERT J GUIDOS	DIRECTOR, PUBLIC POLICY & GOV'T RELATIONS
JULIE HANTMAN	SENIOR PROGRAM OFFICER FOR PUBLIC HEALTH
CHRISTINE LUBINSKI	—
R MICHAEL OCHS	GOVERNMENT RELATIONS ASSOCIATE
BETH RADA	PROGRAM OFFICER FOR SCIENCE & RESEARCH
JASON SCULL	PROGRAM OFFICER FOR CLINICAL AFFAIRS
ANDREA WEDDLE	ASSOCIATE DIRECTOR, HIV MEDICINE ASSOICIATION

Contacted: Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; Centers For Disease Control & Prevention (CDC)

Budget/Appropriations BUD

Funding support for the Centers for Disease Control and Prevention, National Institutes of Health, Health Resources and Services Administration, Food and Drug Administration and global programs for various infectious diseases related issues.

Lobbyist	Covered position, as disclosed
ROBERT J GUIDOS	DIRECTOR, PUBLIC POLICY & GOV'T RELATIONS
JULIE HANTMAN	SENIOR PROGRAM OFFICER FOR PUBLIC HEALTH
CHRISTINE LUBINSKI	—
R MICHAEL OCHS	GOVERNMENT RELATIONS ASSOCIATE
BETH RADA	PROGRAM OFFICER FOR SCIENCE & RESEARCH
JASON SCULL	PROGRAM OFFICER FOR CLINICAL AFFAIRS
ANDREA WEDDLE	ASSOCIATE DIRECTOR, HIV MEDICINE ASSOICIATION

Contacted: Health Resources & Services Administration (HRSA); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.